Kairos Pharma, LTD. (KAPA)
Data as of , from SEC Form 4 filings.
See up to 3 months of KAPA. The 7-day demo opens the 1M and 3M ranges and puts KAPA on your watchlist.
Start 7-day demoLatest KAPA insider trades
About Kairos Pharma, LTD. (KAPA)
Kairos Pharma, LTD. files with the SEC under CIK 0001962011 and is classified as pharmaceutical preparations. We track it alongside the rest of the Health Care sector.
KAPA Form 4 activity by transaction type, last 90 days
No Form 4 activity for KAPA in the last 90 days.
KAPA insider transactions (Form 4)
1210 Form 4 filings on record, the earliest from Nov 21, 2024, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
 Neil Bhowmick - Officer | Grant or award | COMMON STOCK | 171,756 | $0.00 | - | |
| Hyun W. Bae - Director | Grant or award | COMMON STOCK | 10,000 | $0.00 | - | |
| Hyun W. Bae - Director | Grant or award | COMMON STOCK | 19,084 | $0.00 | - | |
| Doug Samuelson - Officer | Grant or award | COMMON STOCK | 152,672 footnote F1 | $0.00 | - | |
| ||||||
| Ramachandran Murali - Officer | Grant or award | COMMON STOCK | 152,672 footnote F1 | $0.00 | - | |
| ||||||
| Hansoo Michael Keyoung - Director | Grant or award | COMMON STOCK | 10,000 footnote F1 | $0.00 | - | |
| Hansoo Michael Keyoung - Director | Grant or award | COMMON STOCK | 19,084 footnote F3 | $0.00 | - | |
| ||||||
| John S. Yu - Officer | Grant or award | COMMON STOCK | 190,840 footnote F1 | $0.00 | - | |
| ||||||
| Rahul Singhvi - Director | Grant or award | COMMON STOCK | 19,084 footnote F1 | $0.00 | - | |
| ||||||
| Doug Samuelson - Officer | Open-market purchase | COMMON STOCK | 2,500 | $1.50 | $4K | |
| Ramachandran Murali - Officer | Open-market purchase | COMMON STOCK | 200 | $1.59 | $318 | |
| John S. Yu - Officer | Open-market purchase | COMMON STOCK | 4,000 | $1.44 | $6K | |
KAPA insider trading FAQ
What is the latest insider trade for KAPA?
Kairos Pharma, LTD. (KAPA) has filed no insider reports in the last 90 days. The most recent on record is dated 2025-12-30. The full record for KAPA runs to 10 Form 4 filings, the earliest from 2024-11-21. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying KAPA stock?
No insider purchases of KAPA were filed in the last 90 days. 3 purchases are on record for this company.
How many insiders are selling KAPA stock?
No insider sales of KAPA were filed in the last 90 days.
Where can I see KAPA SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects KAPA Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Neil Bhowmick view on EDGAR
- - Hyun W. Bae view on EDGAR
- - Doug Samuelson view on EDGAR
- - Ramachandran Murali view on EDGAR
- - Hansoo Michael Keyoung view on EDGAR
- - John S. Yu view on EDGAR
- - Rahul Singhvi view on EDGAR
- - Doug Samuelson view on EDGAR
- - Ramachandran Murali view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where KAPA's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow KAPA with a 7-day demo
- KAPA on your watchlist
- Every KAPA Form 4 filing on record
- Up to 3 months of KAPA price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
